Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Contineum Therapeutics, Inc. | Chief Scientific Officer | Class A Common Stock | 176K | Apr 4, 2024 | Direct | ||
Contineum Therapeutics, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 100K | May 24, 2024 | Direct | ||
Contineum Therapeutics, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 3.7K | May 24, 2024 | By Spouse | ||
Contineum Therapeutics, Inc. | Chief Scientific Officer | Class A Common Stock | 3.57K | Apr 4, 2024 | By Spouse |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTNM | Contineum Therapeutics, Inc. | May 24, 2024 | 2 | $0 | 4 | May 29, 2024 | Chief Scientific Officer |
CTNM | Contineum Therapeutics, Inc. | Apr 4, 2024 | 0 | $0 | 3 | Apr 4, 2024 | Chief Scientific Officer |